390 related articles for article (PubMed ID: 17123400)
1. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
Komvilaisak P; Connolly B; Naqvi A; Blanchette V
Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
[TBL] [Abstract][Full Text] [Related]
2. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
[TBL] [Abstract][Full Text] [Related]
3. Consensus recommendations for use of central venous access devices in haemophilia.
Ewenstein BM; Valentino LA; Journeycake JM; Tarantino MD; Shapiro AD; Blanchette VS; Hoots WK; Buchanan GR; Manco-Johnson MJ; Rivard GE; Miller KL; Geraghty S; Maahs JA; Stuart R; Dunham T; Navickis RJ
Haemophilia; 2004 Sep; 10(5):629-48. PubMed ID: 15357790
[TBL] [Abstract][Full Text] [Related]
4. Venous access in haemophilic children: choice and management.
Santagostino E; Mancuso ME
Haemophilia; 2010 Jan; 16 Suppl 1():20-4. PubMed ID: 20059565
[TBL] [Abstract][Full Text] [Related]
5. Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.
Jeng MR; O'Brien M; Wong W; Zoland J; Lea J; Tang N; Glader B
Haemophilia; 2009 Nov; 15(6):1272-80. PubMed ID: 19601989
[TBL] [Abstract][Full Text] [Related]
6. MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia.
Ranta S; Kalajoki-Helmiö T; Pouttu J; Mäkipernaa A
Haemophilia; 2012 Jul; 18(4):521-6. PubMed ID: 22176603
[TBL] [Abstract][Full Text] [Related]
7. Central venous access device-related infections in patients with haemophilia.
Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
[TBL] [Abstract][Full Text] [Related]
8. Central venous access devices in children with hemophilia: an update.
Blanchette VS; Al-Musa A; Stain AM; Ingram J; Fille RM
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S11-4. PubMed ID: 9351530
[TBL] [Abstract][Full Text] [Related]
9. The use of central venous catheters in haemophilia patients.
Izzi G; Franchini M; Bonetti L; Tagliaferri A
Haemophilia; 2010 Jan; 16 Suppl 1():29-31. PubMed ID: 20059567
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
[TBL] [Abstract][Full Text] [Related]
11. Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy.
Hacker MR; Page JH; Shapiro AD; Rich-Edwards JW; Manco-Johnson MJ
J Pediatr Hematol Oncol; 2007 Jul; 29(7):458-64. PubMed ID: 17609623
[TBL] [Abstract][Full Text] [Related]
12. Central venous access devices in patients with hemophilia.
Valentino LA; Kapoor M
Expert Rev Med Devices; 2005 Nov; 2(6):699-711. PubMed ID: 16293097
[TBL] [Abstract][Full Text] [Related]
13. Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients.
Rajpurkar M; Boldt-Macdonald K; McLenon R; Callaghan MU; Chitlur M; Lusher JM; Becker C
Haemophilia; 2009 Nov; 15(6):1267-71. PubMed ID: 19659937
[TBL] [Abstract][Full Text] [Related]
14. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
[TBL] [Abstract][Full Text] [Related]
15. Venous access in the management of hemophilia.
Valentino LA; Kawji M; Grygotis M
Blood Rev; 2011 Jan; 25(1):11-5. PubMed ID: 21030121
[TBL] [Abstract][Full Text] [Related]
16. Central venous access catheters in children with haemophilia.
Blanchette VS; al-Musa A; Stain AM; Filler RM; Ingram J
Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S39-44. PubMed ID: 8735796
[TBL] [Abstract][Full Text] [Related]
17. The risk associated with indwelling catheters in children with haemophilia.
Ljung R
Br J Haematol; 2007 Sep; 138(5):580-6. PubMed ID: 17686052
[TBL] [Abstract][Full Text] [Related]
18. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study.
Rodriguez V; Mancuso ME; Warad D; Hay CR; DiMichele DM; Valentino L; Kenet G; Kulkarni R
Haemophilia; 2015 Sep; 21(5):e369-74. PubMed ID: 26178581
[TBL] [Abstract][Full Text] [Related]
19. Radiologic placement of a low profile implantable venous access port in a pediatric population.
Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
[TBL] [Abstract][Full Text] [Related]
20. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]